COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,580 Articles (22,415 medRxiv, 8,165 bioRxiv)

Most recent first Previous |  Page 2381: Articles 23801-23810  | Next

The effect of border controls on the risk of COVID-19 reincursion from international arrivals
Steyn, N., Binny, R. N., Hendy, S. C., James, A., Lustig, A., Plank, M. J.
10.1101/2020.07.15.20154955 — Posted: 2020-07-22
Kinetics and Isotype Assessment of Antibodies Targeting the Spike Protein Receptor Binding Domain of SARS-CoV-2 In COVID-19 Patients as a function of Age and Biological Sex.
Graham, N. R., Whitaker, A. N., Strother, C. A., Miles, A. K., Grier, D., McElvany, B. D., Bruce, E. A., Poynter, M. E., Pierce, K. K., Kirkpatrick, B. D., Stapleton, R. D., An, G., Botten, J. W., Crothers, J. W., Diehl, S. A.
10.1101/2020.07.15.20154443 — Posted: 2020-07-22 Discussion: Onsite
The Trans-omics Landscape of COVID-19
Wu, P., Chen, D., Ding, W., Wu, P., Hou, H., Bai, Y., Zhou, Y., Li, K., Xiang, S., Liu, P., Ju, J., Guo, E., Liu, J., Yang, B., Fan, J., He, L., Sun, Z., Feng, L., Wang, J., Wu, T., Wang, H., Cheng, J., Xing, H., Meng, Y., Li, Y., Zhang, Y., Luo, H., Xie, G., Lan, X., Tao, Y., Yuan, H., Huang, K., Sun, W., Qian, X., Li, Z., Huang, M., Ding, P., Wang, H., Qiu, J., Wang, F., Wang, S., Zhu, J., Ding, X., Chai, C., Liang, L., Wang, X., Luo, L., Sun, Y., Yang, Y., Zhuang, Z., Li, T., Tian, L., Zhang, S., Zhu, L., Chen, L., Wu, Y., Ma, X., Chen, F., Ren, Y., Xu, X., Liu, S., Wang, J., Yang, H., Wang, L., Sun, C., Ma, D., Jin, X., Chen, G.
10.1101/2020.07.17.20155150 — Posted: 2020-07-22
Importation of SARS-CoV-2 following the "semaine de relache" and Quebec's (Canada) COVID-19 burden - a mathematical modeling study
Godin, A., Xia, Y., Buckeridge, D. L., Mishra, S., Douwes-Schultz, D., Shen, Y., Lavigne, M., Drolet, M., Schmidt, A. M., Brisson, M., Maheu-Giroux, M.
10.1101/2020.07.20.20158451 — Posted: 2020-07-22
Examining COVID19 Positivity-Ratio Trends in US States from April-July: Are Rising Caseloads Attributable to and Do State Political-Affiliations Play a Role?
Sen, B. P., Padalabalanarayanan, S.
10.1101/2020.07.20.20158485 — Posted: 2020-07-22
Rapid quantitative screening assay for SARS-CoV-2 neutralizing antibodies using HiBiT-tagged virus-like particles
Miyakawa, K., Jeremiah, S. S., Ohtake, N., Matsunaga, S., Yamaoka, Y., Nishi, M., Morita, T., Saji, R., Nishii, M., Kimura, H., Hasegawa, H., Takeuchi, I., Ryo, A.
10.1101/2020.07.20.20158410 — Posted: 2020-07-22
Optimal Size of COVID-19 Testing Pools
cohen, j. D.
10.1101/2020.07.20.20158436 — Posted: 2020-07-22
Assessing the relative contributions of healthcare protocols for epidemic control: an example with network transmission model for COVID-19
Baumgartner, M. T., Lansac-Toha, F. M.
10.1101/2020.07.20.20158576 — Posted: 2020-07-22
Invasive pulmonary aspergillosis in critically ill patients with severe COVID-19 pneumonia: results from the prospective AspCOVID-19 study
Lahmer, T.
10.1101/2020.07.21.20158972 — Posted: 2020-07-22
In-silico modeling of COVID-19 ARDS: pathophysiological insights and potential management implications
Das, A., Saffaran, S., Chikhani, M., Scott, T., Laviola, M., Yehya, N., Laffey, J., Hardman, J. G., Bates, D. G.
10.1101/2020.07.21.20158659 — Posted: 2020-07-22

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).